Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenon after aneurysmal subarachnoid hemorrhage
2019-001542-17Phase 2Active
- Sponsor
- Timo Laitio
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of oxygen in subarachnoid hemorrhage (SAH) (2 arms), sponsored by Timo Laitio. Primary endpoint: Global fractional anisotropy of white matter on diffusion tensor imaging. Started Jul 2020; status: active.
02
Drugs
oxygen
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on 2019-001542-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001542-17.